The TRIM22-CDT2 axis is the key mediator of the p53-Rb signals in growth control of HPV-positive cervical carcinoma cells
Persistent infection with high-risk human papillomavirus (HPV) is the primary contributor to the development of cervical cancer. Although HPV oncoproteins E6 and E7 clearly trigger cervical tumorigenesis by inactivating p53 and Rb pathways, the downstream mediators of p53/Rb inactivation remain elus...
Saved in:
| Main Authors: | Qing Zhou, Hongfei Yu, Anliang Dong, Jiani Yi, Jia Li, Xufan Li, Liyuan Zhou, Qiongzi Qiu, Bingjian Lu, Honghe Zhang, Weiguo Lu, Yi Sun, Pengyuan Liu, Yan Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Neoplasia: An International Journal for Oncology Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558625000892 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic analysis identifies TRIM22 as an oncogenic and immunological biomarker in glioma
by: Yuanyuan Hu, et al.
Published: (2025-07-01) -
TRIM22 promotes glioblastoma development by ubiquitinating Bcl-2
by: Jiahao Zhang, et al.
Published: (2025-12-01) -
OVERVIEW OF CLASS-I TRIPARTITE MOTIF (TRIM) PROTEINS SPECIFICALLY TRIM67
by: S. N. Panhwar, et al.
Published: (2024-12-01) -
E3 ligase TRIM22 promotes melanoma proliferation by regulating cell cycle progression through K63-linked ubiquitination of p21
by: Chen-xing Jin, et al.
Published: (2025-07-01) -
TRIM25, TRIM28 and TRIM59 and Their Protein Partners in Cancer Signaling Crosstalk: Potential Novel Therapeutic Targets for Cancer
by: De Chen Chiang, et al.
Published: (2024-09-01)